034940 — ChoA Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapSucker Stock

Annual income statement for ChoA Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	65,360	57,561	68,880	62,974	62,694
Cost of Revenue
Gross Profit	26,408	20,309	26,242	23,761	21,199
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	68,076	66,501	69,469	71,798	72,393
Operating Profit	-2,716	-8,940	-589	-8,824	-9,699
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,767	-7,146	-424	-10,934	-10,031
Provision for Income Taxes
Net Income After Taxes	-1,606	-8,043	515	-11,133	-10,168
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,319	-8,044	561	-10,514	-9,605
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,319	-8,044	561	-10,514	-9,605
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-23.1	-219	20.3	-300	-310
Dividends per Share